Literature DB >> 20127898

Surgical resection for pulmonary metastasis from hepatocellular carcinoma: analysis of prognosis in relation to primary control.

Chang Young Lee1, Mi Kyung Bae, In Kyu Park, Dae Joon Kim, Jin Gu Lee, Jin Sub Choi, Kwang-Hyub Han, Kyung Young Chung.   

Abstract

BACKGROUND: Advances in local treatments for hepatocellular carcinoma (HCC) have seen better prognosis. There were few studies on surgery for pulmonary metastasis from HCC controlled by local treatment. This study was conducted to analyze prognostic factors after surgery for pulmonary metastasis from HCC.
METHODS: We reviewed 32 patients who underwent surgery for pulmonary metastasis from HCC and analyzed prognostic factors.
RESULTS: HCC was controlled by surgery in 16 patients and by local treatment in 16 patients at the time of pulmonary resection. The median survival time after pulmonary resection was significantly better for HCC controlled by surgery, disease-free time >or=12 months, TMN stage I-II, and T factor 1-2 of primary HCC. The median survival time was better for lesion <or=2 and Child-Pugh score A, but they were not significant (P = 0.053, 0.069). In multivariate analysis, HCC controlled by surgical treatment (P = 0.008), and lesion <or=2 (P = 0.030) were independent prognostic factors.
CONCLUSION: Our Results indicated that surgical resection for pulmonary metastasis from HCC might be beneficial for patients whose HCC was controlled by surgery and the number of lesions was lower than 3. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20127898     DOI: 10.1002/jso.21487

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  14 in total

1.  Risk factors, clinical features, and prognosis of the hepatocellular carcinoma with peritoneal metastasis.

Authors:  Min-Sun Kwak; Jeong-Hoon Lee; Jung-Hwan Yoon; Su Jong Yu; Eun Ju Cho; Eun Sun Jang; Yoon Jun Kim; Hyo-Suk Lee
Journal:  Dig Dis Sci       Date:  2011-12-07       Impact factor: 3.199

2.  Pure transcatheter arterial chemoembolization therapy for intrahepatic tumors causes a shrink in pulmonary metastases of hepatocellular carcinoma.

Authors:  Huiyong Wu; Wei Zhao; Shuguang Liu; Jinsong Zheng; Guanglei Ji; Yinfa Xie
Journal:  Int J Clin Exp Med       Date:  2015-01-15

Review 3.  Long-Term Survival and Prognostic Factors of Pulmonary Metastasectomy in Liver Cancer: A Systematic Review and Meta-Analysis.

Authors:  Chong Wang; Lei Yang; Zikun Liang; Yaodong Liu; Shuku Liu
Journal:  World J Surg       Date:  2018-07       Impact factor: 3.352

4.  Efficacy of capecitabine and oxaliplatin regimen for extrahepatic metastasis of hepatocellular carcinoma following local treatments.

Authors:  Sheng-Li He; Jie Shen; Xian-Jun Sun; Xiao-Juan Zhu; Lu-Ming Liu; Jing-Cheng Dong
Journal:  World J Gastroenterol       Date:  2013-07-28       Impact factor: 5.742

5.  Resection of pulmonary metastases from hepatocellular carcinoma following liver transplantation.

Authors:  Shin Hwang; Yong-Hee Kim; Dong Kwan Kim; Chul-Soo Ahn; Deog-Bok Moon; Ki-Hun Kim; Tae-Yong Ha; Gi-Won Song; Dong-Hwan Jung; Hyeong Ryul Kim; Gil-Chun Park; Jeong-Man Namgoong; Sam-Youl Yoon; Sung-Won Jung; Seung Il Park; Sung-Gyu Lee
Journal:  World J Surg       Date:  2012-07       Impact factor: 3.352

Review 6.  Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition).

Authors:  Hui-Chuan Sun; Jian Zhou; Zheng Wang; Xiufeng Liu; Qing Xie; Weidong Jia; Ming Zhao; Xinyu Bi; Gong Li; Xueli Bai; Yuan Ji; Li Xu; Xiao-Dong Zhu; Dousheng Bai; Yajin Chen; Yongjun Chen; Chaoliu Dai; Rongping Guo; Wenzhi Guo; Chunyi Hao; Tao Huang; Zhiyong Huang; Deyu Li; Gang Li; Tao Li; Xiangcheng Li; Guangming Li; Xiao Liang; Jingfeng Liu; Fubao Liu; Shichun Lu; Zheng Lu; Weifu Lv; Yilei Mao; Guoliang Shao; Yinghong Shi; Tianqiang Song; Guang Tan; Yunqiang Tang; Kaishan Tao; Chidan Wan; Guangyi Wang; Lu Wang; Shunxiang Wang; Tianfu Wen; Baocai Xing; Bangde Xiang; Sheng Yan; Dinghua Yang; Guowen Yin; Tao Yin; Zhenyu Yin; Zhengping Yu; Bixiang Zhang; Jialin Zhang; Shuijun Zhang; Ti Zhang; Yamin Zhang; Yubao Zhang; Aibin Zhang; Haitao Zhao; Ledu Zhou; Wu Zhang; Zhenyu Zhu; Shukui Qin; Feng Shen; Xiujun Cai; Gaojun Teng; Jianqiang Cai; Minshan Chen; Qiang Li; Lianxin Liu; Weilin Wang; Tingbo Liang; Jiahong Dong; Xiaoping Chen; Xuehao Wang; Shusen Zheng; Jia Fan
Journal:  Hepatobiliary Surg Nutr       Date:  2022-04       Impact factor: 7.293

7.  Clinical Significance of Multiple Pulmonary Metastasectomy for Hepatocellular Carcinoma.

Authors:  Shinjiro Mizuguchi; Noritoshi Nishiyama; Nobuhiro Izumi; Takuma Tsukioka; Hiroaki Komatsu; Takashi Iwata; Shogo Tanaka; Shigekazu Takemura; Shoji Kubo
Journal:  World J Surg       Date:  2016-02       Impact factor: 3.352

8.  Clinical Factors Predicting Better Survival Outcome for Pulmonary Metastasectomy of Hepatocellular Carcinoma.

Authors:  Tse-Ming Kuo; Kai-Ming Chang; Tsun-I Cheng; Kuo-Jang Kao
Journal:  Liver Cancer       Date:  2017-08-29       Impact factor: 11.740

9.  Positive lymph node metastasis has a marked impact on the long-term survival of patients with hepatocellular carcinoma with extrahepatic metastasis.

Authors:  Feng Xia; Lin Wu; Wan-Yee Lau; Guo Li; Hongbo Huan; Cheng Qian; Kuansheng Ma; Ping Bie
Journal:  PLoS One       Date:  2014-04-23       Impact factor: 3.240

10.  Efficacy of surgical resection for pulmonary metastases from hepatocellular carcinoma.

Authors:  Yan-Ming Zhou; Xiao-Feng Zhang; Feng Yu; Xiao-Bin Liu; Lu-Peng Wu; Bin Li; Jia-Mei Yang
Journal:  Med Sci Monit       Date:  2014-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.